1. Home
  2. MDT

as 05-24-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Founded: 1949 Country:
Ireland
Ireland
Employees: N/A City: DUBLIN
Market Cap: 114.1B IPO Year: N/A
Target Price: $94.45 AVG Volume (30 days): 6.0M
Analyst Decision: Buy Number of Analysts: 12
Dividend Yield: 3.40% Dividend Payout Frequency: Quarterly
EPS: 3.14 EPS Growth: 3.29
52 Week Low/High: $68.84 - $91.00 Next Earning Date: 05-23-2024
Revenue: $32,320,000,000 Revenue Growth: 5.03%
Revenue Growth (this year): 4.27% Revenue Growth (next year): 4.16%

Share on Social Networks:

Stock Insider Trading Activity of Medtronic plc. (MDT)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Marinaro Michael MDT EVP & President, Surgical OU Apr 8 '24 Sell $83.14 854 $71,001.56 27,925 SEC Form 4
Salmon Sean MDT EVP & President Cardiovascular Feb 21 '24 Sell $85.12 16,035 $1,364,899.20 48,289 SEC Form 4
Salmon Sean MDT EVP & President Cardiovascular Feb 21 '24 Sell $85.15 13,066 $1,112,569.90 64,324 SEC Form 4
Salmon Sean MDT EVP & President Cardiovascular Feb 21 '24 Sell $85.06 1,594 $135,585.64 77,390 SEC Form 4